Latest Oncopeptides AB Stories
STOCKHOLM, April 19, 2010 /PRNewswire/ -- Oncopeptides AB, a Karolinska Development portfolio company, today announced that Alan Hulme was elected Chairman of the Board at the annual general meeting. Mr Hulme has over 30 years experience in the life science business and wide experience in many sectors and geographic locations. "We are fortunate to have Alan as the Chairman of the Board and I look forward to his contribution to the development of the company" says Dr Jack Spira CEO of...
- Exultant; jubilant; triumphant; on the high horse.
- Tipsy; slightly intoxicated.